Publications by authors named "Tomas Magee"

Claim this Profile
N
Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice.
Meghan M Flaherty, Timothy K MacLachlan, Misty Troutt, Tomas Magee, Nadine Tuaillon

Toxicol Sci· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis